Eradication of Taenia solium cysticercosis: A role for vaccination of pigs

International Journal for Parasitology

Volumn 40, Issue 10, 2010, Pages 1183-1192

  Lightowlers, Marshall W ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Control; Cysticercosis; Neurocysticercosis; Pig; Taenia solium; TSOL18; Vaccine

Indexed keywords

CYSTICERCOSIS VACCINE; NICLOSAMIDE; OXFENDAZOLE; PARASITE ANTIGEN; PRAZIQUANTEL; QUIL A; TAENIA SOLIUM ANTIGEN; UNCLASSIFIED DRUG; VACCINE;

INTERMEDIATE HOST; PARASITE CONTROL; PARASITE TRANSMISSION; PIG; VACCINATION; VACCINE;

ADJUVANT THERAPY; ANTIBODY TITER; ARTICLE; COMMUNITY PROGRAM; COST BENEFIT ANALYSIS; CYSTICERCOSIS; DEVELOPING COUNTRY; ENDEMIC DISEASE; ENVIRONMENTAL SANITATION; ERADICATION THERAPY; HEALTH EDUCATION; HOST PARASITE INTERACTION; HUMAN; LOADING DRUG DOSE; NEUROCYSTICERCOSIS; NONHUMAN; ONCOSPHERE; PARASITE CONTROL; PARASITE TRANSMISSION; PIG FARMING; REINFECTION; SCHISTOSOMIASIS; SINGLE DRUG DOSE; SWINE DISEASE; TAENIASIS; ZOONOSIS;

ANIMALS; CYSTICERCOSIS; SWINE; SWINE DISEASES; TAENIA SOLIUM; VACCINATION; VACCINES;

SUIDAE; TAENIA SOLIUM;

EID: 77954029345     PISSN: 00207519     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpara.2010.05.001     Document Type: Article

References (74)

1. Allan J.C., Craig P.S., Pawlowski Z.S. Control of Taenia solium with emphasis on treatment of taeniasis. Taenia solium Cysticercosis from Basic to Clinical Science 2002, 411-420. CABI Publishing, Wallingford. G. Singh, S. Prabhakar (Eds.).
2. Allan J.C., Velasquez-Tohom M., Fletes C., Torres-Alvarez R., Lopez-Virula G., Yurrita P., Soto de Alfaro H., Rivera A., Garcia-Noval J. Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Trans. R. Soc. Trop. Med. Hyg. 1997, 91:595-598.
3. Assana, E., Amadou, F., Thys, E., Lightowlers, M.W., Zoli, A.P., Dorny, P., Geerts, S., in press. Pig-farming systems and porcine cysticercosis in the north of Cameroon. J. Helminthol., doi:10.1017/S0022149X10000167.
4. Assana E., Kyngdon C.T., Gauci C.G., Geerts S., Dorny P., De Deken R., Anderson G.A., Zoli A., Lightowlers M.W. Elimination of Taenia solium transmission to pigs in a field trial of the TSOL18 vaccine in Cameroon. Int. J. Parasitol. 2010, 40:515-519.
5. Baston A. The costs and economics of modern vaccine development. Orphan Vaccines 2002, 15-24. Karger, Basel. F. Brown, I. Gust (Eds.).
6. Cai X., Yuan G., Zheng Y., Luo X., Zhang S., Ding J., Jing Z., Lu C. Effective production and purification of the glycosylated TSOL18 antigen, which is protective against pig cysticercosis. Infect. Immun. 2008, 76:767-770.
7. Canning D. Priority setting and the 'neglected' tropical diseases. Trans. R. Soc. Trop. Med. Hyg. 2006, 100:499-504.
8. Craig P.S., Larrieu E. Control of cystic echinococcosis/hydatidosis: 1863-2002. Adv. Parasitol. 2006, 61:443-508.
9. Cruz M., Davis A., Dixon H., Pawlowski Z.S., Proano J. Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. Bull. World Health Org. 1989, 67:401-407.
10. de Aluja A.S., Villalobos A.N.M., Plancarte A., Rodarte L.F., Hernandez M., Sciutto E. Experimental Taenia solium cysticercosis in pigs: characteristics of the infection and antibody response. Vet. Parasitol. 1996, 61:49-59.
11. de Aluja A.S., Villalobos N.M., Nava G., Toledo A., Martinez J.J., Plancarte A., Rodarte L.F., Fragoso G., Sciutto E. Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs. Vaccine 2005, 23:4062-4069.
12. Diaz Camacho S.P., Candil Ruiz A., Suate Peraza V., Zazueta Ramos M.L., Felix Medina M., Lozano R., Willms K. Epidemiologic study and control of Taenia solium infections with praziquantel in a rural village of Mexico. Am. J. Trop. Med. Hyg. 1991, 45:522-531.
13. The Eradication of Infectious Diseases: Report of the Dahlem Workshop on the Eradication of Infectious Diseases, Berlin, March 16-22, 1997 1998, John Wiley and Sons, Chichester, New York. W.R. Dowdle, D.R. Hopkins (Eds.).
14. Eckert J., Gemmell M.A., Soulsby E.J.L. FAO/UNEP/WHO Guidelines for the Surveillance, Prevention and Control of Echinococcosis/Hydatidosis 1981, World Health Organization, Geneva.
15. Engels D., Urbani C., Belotto A., Meslin F., Savioli L. The control of human (neuro)cysticercosis: which way forward?. Acta Trop. 2003, 87:177-182.
16. Flisser A., Gauci C.G., Zoli A., Martinez-Ocana J., Garza-Rodriguez A., Dominguez-Alpizar J.L., Maravilla P., Rodriguez-Canul R., Avila G., Aguilar-Vega L., Kyngdon C., Geerts S., Lightowlers M.W. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infect. Immun. 2004, 72:5292-5297.
17. Flisser A., Madrazo I., Plancarte A., Schantz P., Allan J., Craig P., Sarti E. Neurological symptoms in occult neurocysticercosis after single taeniacidal dose of praziquantel. Lancet 1993, 342:748.
18. Flisser A., Rodriguez-Canul R., Willingham A.L. Control of the taeniosis/cysticercosis complex: future developments. Vet. Parasitol. 2006, 139:283-292.
19. Flisser A., Sarti E., Lightowlers M., Schantz P. Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Trop. 2003, 87:43-51.
20. Garcia H.H., Gonzalez A.E., Del Brutto O.H., Tsang V.C., Llanos-Zavalaga F., Gonzalvez G., Romero J., Gilman R.H. Strategies for the elimination of taeniasis/cysticercosis. J. Neurol. Sci. 2007, 262:153-157.
21. Garcia H.H., Gonzalez A.E., Evans C.A., Gilman R.H. Taenia solium cysticercosis. Lancet 2003, 362:547-556.
22. Garcia H.H., Gonzalez A.E., Gilman R.H., Moulton L.H., Verastegui M., Rodriguez S., Gavidia C., Tsang V.C. Combined human and porcine mass chemotherapy for the control of T. Solium. Am. J. Trop. Med. Hyg. 2006, 74:850-855.
23. Gauci C.G., Flisser A., Lightowlers M.W. A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18kDa antigens. Int. J. Parasitol. 1998, 28:757-760.
24. Gauci C.G., Lightowlers M.W. Alternative splicing and sequence diversity of transcripts from the oncosphere stage of Taenia solium with homology to the 45W antigen of Taenia ovis. Mol. Biochem. Parasitol. 2001, 112:173-181.
25. Gauci C.G., Verastegui M.R., Gilman R.H., Lightowlers M.W. Taenia solium and Taenia ovis: stage-specific expression of the vaccine antigen genes, TSOL18, TSOL16, and homologues, in oncospheres. Exp. Parasitol. 2006, 113:272-275.
26. Gilman R.H., Garcia H.H., Gonzalez A.E., Dunleavy M., Verastegui M., Peru T.C.W.G.I. Shorts cuts to development: methods to control the transmission of cysticercosis in developing countries. Taenia solium Taeniasis/Cysticercosis 1999, 313-326. Editorial Universo, Lima. H.H. Garcia, M. Martinez (Eds.).
27. Gonzales A.E., Garcia H.H., Gilman R.H., Gavidia C.M., Tsang V.C., Bernal T., Falcon N., Romero M., Lopez-Urbina M.T. Effective, single-dose treatment or porcine cysticercosis with oxfendazole. Am. J. Trop. Med. Hyg. 1996, 54:391-394.
28. Gonzalez A.E., Falcon N., Gavidia C., Garcia H.H., Tsang V.C., Bernal T., Romero M., Gilman R.H. Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Vet. Rec. 1997, 141:420-422.
29. Gonzalez A.E., Falcon N., Gavidia C., Garcia H.H., Tsang V.C., Bernal T., Romero M., Gilman R.H. Time-response curve of oxfendazole in the treatment of swine cysticercosis. Am. J. Trop. Med. Hyg. 1998, 59:832-836.
30. Gonzalez A.E., Garcia H.H., Gilman R.H., Tsang V.C.W. Control of Taenia solium. Acta Trop. 2003, 87:103-109.
31. Gonzalez A.E., Gauci C.G., Barber D., Gilman R.H., Tsang V.C., Garcia H.H., Verastegui M., Lightowlers M.W. Vaccination of pigs to control human neurocysticercosis. Am. J. Trop. Med. Hyg. 2005, 72:837-839.
32. Gonzalez A.E., Gavidia C., Falcon N., Bernal T., Verastegui M., Garcia H.H., Gilman R.H., Tsang V.C. Protection of pigs with cysticercosis from further infections after treatment with oxfendazole. Am. J. Trop. Med. Hyg. 2001, 65:15-18.
33. Gyapong J.O., Gyapong M., Yellu N., Anakwah K., Amofah G., Bockarie M., Adjei S. Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities. Lancet 2010, 375:160-165.
34. Harrison G.B.L., Heath D.D., Dempster R.P., Lawrence S.B., Lightowlers M.W., Rickard M.D. Identification of host-protective antigens of Taenia ovis oncospheres. Int. J. Parasitol. 1993, 23:41-50.
35. Huerta M., de Aluja A.S., Fragoso G., Toledo A., Villalobos N., Hernandez M., Gevorkian G., Acero G., Diaz A., Alvarez I., Avila R., Beltran C., Garcia G., Martinez J.J., Larralde C., Sciutto E. Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine 2001, 20:262-266.
36. Ito A., Urbani C., Jiamin Q., Vuitton D.A., Dongchuan Q., Heath D.D., Craig P.S., Zheng F., Schantz P.M. Control of echinococcosis and cysticercosis: a public health challenge to international cooperation in China. Acta Trop. 2003, 86:3-17.
37. Johnson K.S., Harrison G.B., Lightowlers M.W., O'Hoy K.L., Cougle W.G., Dempster R.P., Lawrence S.B., Vinton J.G., Heath D.D., Rickard M.D. Vaccination against ovine cysticercosis using a defined recombinant antigen. Nature 1989, 338:585-587.
38. Keilbach N.M., de Aluja A.S., Sarti-Gutierrez E. A programme to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village. Acta Leiden 1989, 57:181-189.
39. Lightowlers M.W. Cestode infections in animals: immunological diagnosis and vaccination. Rev. Sci. Tech. 1990, 9:463-487.
40. Lightowlers M.W. Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. Int. J. Parasitol. 1999, 29:811-817.
41. Lightowlers M.W. Cestode vaccines: origins, current status and future prospects. Parasitology 2006, 133(Suppl.):S27-S42.
42. Lightowlers M.W. Vaccines against cysticercosis and hydatidosis: foundations in taeniid cestode immunology. Parasitol. Int. 2006, 55(Suppl.):S39-S43.
43. Lightowlers M.W., Colebrook A.L., Gauci C.G., Gauci S.M., Kyngdon C.T., Monkhouse J.L., Vallejo Rodriquez C., Read A.J., Rolfe R.A., Sato C. Vaccination against cestode parasites: anti-helminth vaccines that work and why. Vet. Parasitol. 2003, 115:83-123.
44. Lightowlers M.W., Lawrence S.B., Gauci C.G., Young J., Ralston M.J., Maas D., Health D.D. Vaccination against hydatidosis using a defined recombinant antigen. Parasite Immunol. 1996, 18:457-462.
45. Lightowlers M.W., Mitchell G.F., Bowtell D.D., Anders R.F., Rickard M.D. Immunization against Taenia taeniaeformis in mice. studies on the characterization of antigens from oncospheres. Int. J. Parasitol. 1984, 14:321-333.
46. Lightowlers M.W., Rolfe R., Gauci C.G. Taenia saginata: vaccination against cysticercosis in cattle with recombinant oncosphere antigens. Exp. Parasitol. 1996, 84:330-338.
47. Lofthouse S. Immunological aspects of controlled antigen delivery. Adv. Drug Deliv. Rev. 2002, 54:863-870.
48. Mills A. Mass campaigns versus general health services: what have we learnt in 40 years about vertical versus horizontal approaches?. Bull. World Health Org. 2005, 83:315-316.
49. Molinari J.L., Rodriguez D., Tato P., Soto R., Arechavaleta F., Solano S. Field trial for reducing porcine Taenia solium cysticercosis in Mexico by systematic vaccination of pigs. Vet. Parasitol. 1997, 69:55-63.
50. Molinari J.L., Soto R., Tato P., Rodriguez D., Retana A., Sepulveda J., Palet A. Immunization against porcine cysticercosis in an endemic area in Mexico: a field and laboratory study. Am. J. Trop. Med. Hyg. 1993, 49:502-512.
51. Morales J., Martinez J.J., Manoutcharian K., Hernandez M., Fleury A., Gevorkian G., Acero G., Blancas A., Toledo A., Cervantes J., Maza V., Quet F., Bonnabau H., de Aluja A.S., Fragoso G., Larralde C., Sciutto E. Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis. Vaccine 2008, 26:2899-2905.
52. Moreno M., Kramer M.G., Yim L., Chabalgoity J.A. Salmonella as live trojan horse for vaccine development and cancer gene therapy. Curr. Gene Ther. 2010, 10:56-76.
53. WHO/FAO/OIE Guidelines for the Surveillance, Prevention and Control of Taeniasis/Cysticercosis 2005, OIE/WHO/FAO, Paris. K.D. Murrell (Ed.).
54. Ngowi H.A., Carabin H., Kassuku A.A., Mlozi M.R., Mlangwa J.E., Willingham A.L. A health-education intervention trial to reduce porcine cysticercosis in Mbulu District. Tanzania. Prev. Vet. Med. 2008, 85:52-67.
55. Ngowi, H.A., Mlangwa, J.E.D., Carabin, H., Mlozi, M.R.S., Kassuku, A.A., Kimera, S.I., Willingham 3rd, A.L., 2007. Financial efficiency of health and pig management education intervention in controlling porcine cysticercosis in Mbulu District, northern Tanzania. Livestock Res. Rural Dev. 19, article #62.
56. Ngowi H.A., Mlangwa J.E.D., Mlozi M.R.S., Tolma E.L., Kassuku A.A., Carabin H., Willingham A.L. Implementation and evaluation of a health-promotion strategy for control of Taenia solium infections in northern Tanzania. Int. J. Health Promot. Educ. 2009, 47:24-34.
57. Ottsen E.A., Dowdle W.R., Fenner F., Habermehl K.-O., John T.J., Koch M.A., Medley G.F., Muller A.S., Ostroff S.M., Zeichhardt H. Group report: how is eradication to be defined and what are the biological criteria?. The Eradication of Infectious Diseases: Report of the Dahlem Workshop on the Eradication of Infectious Diseases, Berlin, March 16-22, 1997 1998, 47-59. John Wiley and Sons, New York. W.R. Dowdle, D.R. Hopkins (Eds.).
58. Pawlowski Z.S. Efficacy of low doses of praziquantel in taeniasis. Acta Trop. 1990, 48:83-88.
59. Pawlowski Z., Allan J., Sarti E. Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. Int. J. Parasitol. 2005, 35:1221-1232.
60. Rajasekariah G.R., Mitchell G.F., Rickard M.D. Taenia taeniaeformis in mice protective immunization with oncospheres and their products. Int. J. Parasitol. 1980, 10:155-160.
61. Rickard M.D., Williams J.F. Hydatidosis/cysticercosis: immune mechanisms and immunization against infection. Adv. Parasitol. 1982, 21:229-296.
62. Sarti E., Flisser A., Schantz P.M., Gleizer M., Loya M., Plancarte A., Avila G., Allan J., Craig P., Bronfman M., Wijeyaratne P. Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. Am. J. Trop. Med. Hyg. 1997, 56:127-132.
63. Schantz P.M., Cruz M., Sarti E., Pawlowski Z. Potential eradicability of taeniasis and cysticercosis. Bull. Pan Am. Health Org. 1993, 27:397-403.
64. Sarti E., Schantz P.M., Avila G., Ambrosio J., Medina-Santillan R., Flisser A. Mass treatment against human taeniasis for the control of cysticercosis: a population-based intervention study. Trans. R. Soc. Trop. Med. Hyg. 2000, 94:85-89.
65. Schantz P.M., Tsang V.C. The US Centers for Disease Control and Prevention (CDC) and research and control of cysticercosis. Acta Trop. 2003, 87:161-163.
66. Schwendeman S.P. Recent advances in the stabilization of proteins encapsulated in injectable PLGA delivery systems. Crit. Rev. Ther. Drug Carrier Syst. 2002, 19:73-98.
67. Sciutto E., Fragoso G., Aluja A.S.d., Hernandez M., Rosas G., Larralde C. Vaccines against cysticercosis. Curr. Top. Med. Chem. 2008, 8:415-423.
68. Sciutto E., Morales J., Martinez J.J., Toledo A., Villalobos M.N., Cruz-Revilla C., Meneses G., Hernandez M., Diaz A., Rodarte L.F., Acero G., Gevorkian G., Manoutcharian K., Paniagua J., Fragoso G., Fleury A., Larralde R., De Aluja A.S., Larralde C. Further evaluation of the synthetic peptide vaccine S3Pvac against Taenia solium cysticercosis in pigs in an endemic town of Mexico. Parasitology 2007, 134:129-133.
69. Sciutto E., Rosas G., Cruz-Revilla C., Toledo A., Cervantes J., Hernandez M., Hernandez B., Goldbaum F.A., Aluja A.S.d., Fragoso G., Larralde C. Renewed hope for a vaccine against the intestinal adult Taenia solium. J. Parasitol. 2007, 93:824-831.
70. Sikasunge C.S., Johansen M.V., Willingham A.L., Leifsson P.S., Phiri I.K. Taenia solium porcine cysticercosis: viability of cysticerci and persistency of antibodies and cysticercal antigens after treatment with oxfendazole. Vet. Parasitol. 2008, 158:57-66.
71. Wang Q., Sun S., Hu Z., Wu D., Wang Z. Immune response and protection elicited by DNA immunisation against Taenia cysticercosis. Vaccine 2003, 21:1672-1680.
72. Willingham A.L., Engels D. Control of Taenia solium cysticercosis/taeniosis. Adv. Parasitol. 2006, 61:509-566.
73. Wright E.P., Jain S. Human infestation by Taenia saginata lasting over 20 years. Postgrad. Med. J. 1984, 60:495-496.
74. Wu L., Diao Z., Deang X., Gao J., Zhou Z., Liu Y., Wang Y. DNA vaccine against Taenia solium cysticercosis expressed as a modified hepatitis B virus core particle containing three epitopes shared by Taenia crassiceps and Taenia solium. J. Nanosci. Nanotechnol. 2005, 5:1204-1210.